JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M603599200 on April 20, 2006

J. Biol. Chem., Vol. 281, Issue 25, 17034-17043, June 23, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/25/17034    most recent
M603599200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hales, T. G.
Right arrow Articles by Connolly, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hales, T. G.
Right arrow Articles by Connolly, C. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An Asymmetric Contribution to {gamma}-Aminobutyric Type A Receptor Function of a Conserved Lysine within TM2–3 of {alpha}1, beta2, and {gamma}2 Subunits*

Tim G. Hales{ddagger}§1, Tarek Z. Deeb{ddagger}2, Haiyan Tang2, Karen A. Bollan, Dale P. King, Sara J. Johnson, and Christopher N. Connolly

From the {ddagger}Department of Pharmacology & Physiology and the §Department of Anesthesiology & Critical Care Medicine, The George Washington University, Washington, D. C. 20037 and the Department of Pharmacology & Neuroscience, Ninewells Medical School, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom

Mutations that impair the expression and/or function of {gamma}-aminobutyric acid type A (GABAA) receptors can lead to epilepsy. The familial epilepsy {gamma}2(K289M) mutation affects a basic residue conserved in the TM2–3 linker of most GABAA subunits. We investigated the effect on expression and function of the Lys -> Met mutation in mouse {alpha}1(K278M), beta2(K274M), and {gamma}2(K289M) subunits. Compared with cells expressing wild-type and {alpha}1beta2{gamma}2(K289M) receptors, cells expressing {alpha}1(K278M)beta2{gamma}2 and {alpha}1beta2(K274M){gamma}2 receptors exhibited reduced agonist-evoked current density and reduced GABA potency, with no change in single channel conductance. The low current density of {alpha}1beta2(K274M){gamma}2 receptors coincided with reduced surface expression. By contrast the surface expression of {alpha}1(K278M)beta2{gamma}2 receptors was similar to wild-type and {alpha}1beta2{gamma}2(K289M) receptors suggesting that the {alpha}1(K278M) impairs function. In keeping with this interpretation GABA-activated channels mediated by {alpha}1(K278M)beta2{gamma}2 receptors had brief open times. To a lesser extent {gamma}2(K289M) also reduced mean open time, whereas beta2(K274M) had no effect. We used propofol as an alternative GABAA receptor agonist to test whether the functional deficits of mutant subunits were specific to GABA activation. Propofol was less potent as an activator of {alpha}1(K278M)beta2{gamma}2 receptors. By contrast, neither beta2(K274M) nor {gamma}2(K289M) affected the potency of propofol. The beta2(K274M) construct was unique in that it reduced the efficacy of propofol activation relative to GABA. These data suggest that the {alpha}1 subunit Lys-278 residue plays a pivotal role in channel gating that is not dependent on occupancy of the GABA binding site. Moreover, the conserved TM2–3 loop lysine has an asymmetric function in different GABAA subunits.


Received for publication, April 13, 2006

* This work has been supported by the Biotechnology and Biological Sciences and Research Council (Grant 94/C17336 awarded to C. N. C.), Tenovus Scotland (to C. N. C.), Anonymous Trust (to C. N. C.), and the National Institutes of Health (Grant GM058037 awarded to T. G. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

2 Both authors contributed equally to this work.

1 To whom correspondence should be addressed: Dept. of Pharmacology, Medical Center, The George Washington University, 2300 Eye St. NW, Washington, D. C. 20037. Tel.: 202-994-3546; Fax: 202-994-2870; E-mail: phmtgh{at}gwumc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. K. Crawford, D. I. Perkins, J. R. Trudell, E. J. Bertaccini, D. L. Davies, and R. L. Alkana
Roles for Loop 2 Residues of {alpha}1 Glycine Receptors in Agonist Activation
J. Biol. Chem., October 10, 2008; 283(41): 27698 - 27706.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Eugene, C. Depienne, S. Baulac, M. Baulac, J. M. Fritschy, E. Le Guern, R. Miles, and J. C. Poncer
GABAA Receptor {gamma}2 Subunit Mutations Linked to Human Epileptic Syndromes Differentially Affect Phasic and Tonic Inhibition
J. Neurosci., December 19, 2007; 27(51): 14108 - 14116.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. R. McCartney, T. Z. Deeb, T. N. Henderson, and T. G. Hales
Tonically Active GABAA Receptors in Hippocampal Pyramidal Neurons Exhibit Constitutive GABA-Independent Gating
Mol. Pharmacol., February 1, 2007; 71(2): 539 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.